UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

Annals of the Rheumatic Diseases, 2011-03, Vol.70 (3), p.414-422

2011

Volltextzugriff (PDF)

Monitoring patients treated with anti-TNF-α biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

Rheumatology (Oxford, England), 2007-12, Vol.46 (12), p.1828-1834

2007

Volltextzugriff (PDF)

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

The Lancet (British edition), 2009, Vol.374 (9688), p.459-466

2009

Volltextzugriff (PDF)

Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

Rheumatology (Oxford, England), 2007-12, Vol.46 (12), p.1828-1834

2007

Volltextzugriff (PDF)

Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register

Rheumatology (Oxford, England), 2008-04, Vol.47 (4), p.507-513

2008

Volltextzugriff (PDF)

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

Journal of rheumatology, 2005-07, Vol.32 (7), p.1213

2005

Volltextzugriff (PDF)

Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register

Annals of the rheumatic diseases, 2008-03, Vol.67 (3), p.364-369

2008

Volltextzugriff (PDF)

Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine

Lupus, 2017-09, Vol.26 (10), p.1072-1081

2017

Volltextzugriff (PDF)

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

Annals of the rheumatic diseases, 2009-05, Vol.68 (5), p.648-653

2009

Volltextzugriff (PDF)

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

Annals of the rheumatic diseases, 2005-05, Vol.64 (5), p.699-703

2005

Volltextzugriff (PDF)

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

Annals of the rheumatic diseases, 2007-10, Vol.66 (10), p.1339-1344

2007

Volltextzugriff (PDF)

The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug

Scandinavian journal of rheumatology, 2012-02, Vol.41 (1), p.1-9

2012

Volltextzugriff (PDF)

Prevalence of spondyloarthritis and its subtypes in southern Sweden

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.943-948

2011

Volltextzugriff (PDF)

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis

Rheumatology (Oxford, England), 2006-01, Vol.45 (1), p.106-111

2006

Volltextzugriff (PDF)

TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden

Annals of the Rheumatic Diseases, 2004-01, Vol.63 (1), p.4-10

2004

Volltextzugriff (PDF)

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

Annals of the rheumatic diseases, 2005-10, Vol.64 (10), p.1421-1426

2005

Volltextzugriff (PDF)

Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort

Annals of the rheumatic diseases, 2014-05, Vol.73 (5), p.845-853

2014

Volltextzugriff (PDF)

Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients

Rheumatology (Oxford, England), 2007, Vol.46 (4), p.608-611

2007

Volltextzugriff (PDF)

Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register

Rheumatology (Oxford, England), 2008-04, Vol.47 (4), p.495-499

2008

Volltextzugriff (PDF)

Presence of peripheral arthritis and male sex predicting continuation of anti–tumor necrosis factor therapy in ankylosing spondylitis: An observational prospective cohort study from the South Swedish arthritis treatment group register

Arthritis care & research (2010), 2010-10, Vol.62 (10), p.1362-1369

2010

Volltextzugriff (PDF)

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Annals of the rheumatic diseases, 2005-10, Vol.64 (10), p.1414-1420

2005

Volltextzugriff (PDF)

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases

Autoimmunity reviews, 2011-04, Vol.10 (6), p.341-352

2011

Volltextzugriff (PDF)

A survey of spinal collateral actions of feline ventral spinocerebellar tract neurons

The European journal of neuroscience, 2013-02, Vol.37 (3), p.380-392

2013

Volltextzugriff (PDF)

Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression

Clinical and experimental immunology, 2010-07, Vol.161 (1), p.89-97

2010

Volltextzugriff (PDF)

Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients

Rheumatology (Oxford, England), 2007-04, Vol.46 (4), p.608-611

2007

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(156)

Publikationsform

Artikel
(147)
Tagungsberichte
(44)

Sprache

Englisch
(190)
Dänisch
(1)

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(153)
Humans
(108)
Life Sciences & Biomedicine
(106)
Science & Technology
(106)
Clinical Medicine
(98)
Medical And Health Sciences
(98)
Klinisk Medicin
(93)
Rheumatology
(92)
Reumatologi Och Inflammation
(87)
Rheumatology And Autoimmunity
(86)
Female
(84)
Male
(82)
Middle Aged
(80)
Arthritis, Rheumatoid - Drug Therapy
(69)
Adult
(66)
Biological And Medical Sciences
(66)
Medical Sciences
(65)
Antirheumatic Agents - Therapeutic Use
(59)
Diseases Of The Osteoarticular System
(58)
Rheumatoid Arthritis
(57)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

Monitoring patients treated with anti-TNF-α biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register

Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug

Prevalence of spondyloarthritis and its subtypes in southern Sweden

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis

TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort

Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients

Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register

Presence of peripheral arthritis and male sex predicting continuation of anti–tumor necrosis factor therapy in ankylosing spondylitis: An observational prospective cohort study from the South Swedish arthritis treatment group register

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases

A survey of spinal collateral actions of feline ventral spinocerebellar tract neurons

Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression

Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients

Suchergebnisse filtern